Sort
15,842 grants matching “pancreatic cancer”
The role of Dclk1 in the initiation of colorectal cancer
$338,550Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA
The role of Dclk1 in the initiation of colorectal cancer
$338,550Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · CA
Reprogramming Tumor Microenvironment by Nanoparticle
$338,550Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2018 · CA
Reprogramming Tumor Microenvironment by Nanoparticle
$338,550Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · CA
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer
$338,504Aaron M. Mohs · University Of Nebraska Medical Center · R01 · FY2024 · CA
IRAK4 As a Novel Immunotherapeutic Target in Pancreatic Ductal Adenocarcinoma
$338,378Kian H Lim · Washington University · R37 · FY2019 · CA
Prevention of solar UV-induced skin cancer by targeting LTA4H
$338,378Liang Liu · University Of Minnesota · R01 · FY2019 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$338,378David G Denardo · Washington University · R01 · FY2019 · CA
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
$338,377Mayumi Ito · New York University School Of Medicine · U54 · FY2024 · CA
Molecularly guided multimodal theranostics for breast cancer
$338,318Amit Joshi · Baylor College Of Medicine · R01 · FY2011 · CA
MUC16 in Pancreatic Cancer Progression and Metastasis
$338,280Prakash Radhakrishnan · University Of Nebraska Medical Center · R01 · FY2020 · CA
MUC16 in Pancreatic Cancer Progression and Metastasis
$338,280Prakash Radhakrishnan · University Of Nebraska Medical Center · R01 · FY2021 · CA
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$338,263Terence Marques Williams · Ohio State University · R01 · FY2020 · CA
Acoustically Activated Micellar Drug Delivery
$338,251Natalya Y Rapoport · University Of Utah · R01 · FY2008 · EB
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$338,182David G Denardo · Washington University · P50 · FY2017 · CA
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
$338,107David W. Clapp · Indiana University Indianapolis · R01 · FY2008 · CA
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
$338,099David C Linehan · University Of Rochester · R01 · FY2022 · CA
Role of Glypican-1 in Pancreatic Cancer
$338,053Dartmouth College · R01 · FY2005 · CA
Integration of stromal targeting agents with immune checkpoint therapy
$338,040Lei Zheng · Johns Hopkins University · P01 · FY2022 · CA
Role of Mitochondrial Respiratory Stress Signaling in Cancer Progression
$337,968Narayan G Avadhani · University Of Pennsylvania · R01 · FY2009 · CA
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
$337,922Kian H Lim · Washington University · R37 · FY2024 · CA
Regulation of DNA replication kinetics by BRCA2 after DNA damage
$337,877Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Regulation of DNA replication kinetics by BRCA2 after DNA damage
$337,877Bing Xia · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Kinetic analysis of Myc-induced carcinogenesis in vivo
$337,808Gerard Ian Evan · University Of California, San Francisco · R01 · FY2009 · CA
Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
$337,620Ke Sheng · University Of California Los Angeles · R01 · FY2015 · CA